The Path to Global Vaccine Equity

3:00 pm on Thursday, June 10, 2021
4:00 pm on Thursday, June 10, 2021
Virtual Event
Our collective recovery is tied to ensuring equity in global COVID-19 vaccine distribution and administration. Aside from the direct health and health systems impact, the COVID-19 pandemic has and will continue to undo decades of work globally on reducing poverty, improving education and health, and empowering women. When communities can’t equitably access vaccines, it makes it harder for them to recover, and we all continue to suffer collectively from the global economic impact and through appearance of new variants. We speak to three public health leaders and scientists about what is at stake, what the barriers and opportunities are, and how the fight for global COVID-19 vaccine equity now can help us build infrastructure and cooperation against future threats.

Join us on June 10, 2021 at 3 pm for this critical discussion with:

Dr. Joia Mukherjee, MD, MPH Chief Medical Officer, Partners in Health Associate professor of medicine in the Division of Global Health Equity, Department of Medicine, Brigham and Womens’ Hospital

Dr. Rajeev Venkayya, MD President, Global Vaccine Business Unit, Takeda Pharmaceutical Co. Ltd. Board Member, Coalition for Epidemic Preparedness Innovation

Dr. James Lawler, MD, MPH Director, Global Center for Health Security Director, Clinical and Biodefense Research Associate Professor, Department of Internal Medicine, University of Nebraska Medical Center

Moderated by: Dr. Nahid Bhadelia, MD, MALD Director, Center for Emerging Infectious Diseases Policy and Research (CEID), Associate Director, National Emerging Infectious Diseases Laboratories (NEIDL), Boston University Associate Professor, Department of Medicine, BU School of Medicine